DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies

Published:2021-06-11 Issue:1 Volume:16 Page:11-41
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Rominiyi Ola¹²³^ORCID,Collis Spencer J.¹²⁴^ORCID

Affiliation:

1. Weston Park Cancer Centre Sheffield UK

2. Department of Oncology & Metabolism The University of Sheffield Medical School UK

3. Department of Neurosurgery Royal Hallamshire Hospital Sheffield Teaching Hospitals NHS Foundation Trust UK

4. Sheffield Institute for Nucleic Acids (SInFoNiA) University of Sheffield UK

Funder

Royal College of Surgeons of England

Brain Tumour Charity

National Centre for the Replacement Refinement and Reduction of Animals in Research

Sheffield Hospitals Charity

American Association for Cancer Research

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13020

Reference244 articles.

1. Years of life lost (YLL) from cancer is an important measure of population burden — and should be considered when allocating research funds

2. Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

3. Challenges to curing primary brain tumours

4. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017

5. Advances in the molecular genetics of gliomas — implications for classification and therapy

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways;Non-coding RNA Research;2024-12

2. A novel approach to investigate the combinatorial effects of TLK1 (Tousled-Like Kinase1) inhibitors with Temozolomide for glioblastoma therapy;Bioorganic Chemistry;2024-10

3. ClonoScreen3D – A Novel 3-Dimensional Clonogenic Screening Platform for Identification of Radiosensitizers for Glioblastoma;International Journal of Radiation Oncology*Biology*Physics;2024-09

4. Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT;Clinical Cancer Research;2024-06-05

5. Antitumoral Activity of the Universal Methyl Donor S-Adenosylmethionine in Glioblastoma Cells;Molecules;2024-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3